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Background: Thrombocytosis can follow surgery and has occasionally been observed after major orthopaedic
surgery. The aim of the present study was to ascertain the platelet count (PLTC) change in patients admitted to a
rehabilitation unit after major joint surgery and whether deep venous thrombosis (DVT) and poor outcomes
occurred in those who had thrombocytosis.
Method: PLTC, red blood cells (RBC), haemoglobin (Hb), fibrinogen, and D-dimers were assessed in patients on
admission and at discharge after major joint surgery. Functional outcomes were ascertained using the Barthel
Scale (BS), the Functional Independence Measure (FIM) and gait evaluation. Thrombocytosis was considered to
have occurred when PLTC was greater than or equal to 500 × 1009/L. All subjects with thrombocytosis had
ultrasonography to assess DVT occurrence. The patients were divided into “young” and “old” groups according
to an age cut-off of 75 years to investigate potential age-related differences.
Results: Two hundred and seventy-five patients were identified and 142 (36 M and 106 F, mean age 77.2 ± 10.7) were
enrolled. Seventy-six (53.5%) underwent total hip arthroplasty (THA), 40 (51.1%) underwent hip internal fixation
and 26 (18.3%) subjects underwent total knee arthroplasty (TKA). The young and old groups included 60 and
82 patients, respectively. Fifty-nine (42.4%) patients had PLTC above 400 × 1009/L. Of these, 28 (20.1%) had
thrombocytosis with PLTC above 500 × 1009/L, and 15 of them (10.7%) had very high values above 600 × 1009/L.
Increased levels of fibrinogen and D-dimers were also detected. No subject with thrombocytosis had DVT. Outcome
was not affected by PLTC. At discharge, significant improvement in all functional assessments was observed in young
compared to old people; gait: 2.9 ± 0.2 vs. 2.2 ± 0.8; BS: 97 ± 6.9 vs. 70.5 ± 25.6; and FIM: 116.4 ± 10.9 vs. 83.6 ± 31.2
(p < 0.004), respectively. BS and FIM mean scores were positively correlated with Hb level.
Conclusion: Elevated PLTC and thrombocytosis were not uncommon in patients after major joint surgery, but no subject
developed DVT. Platelet count change did not affect the outcome. Higher age and lower haemoglobin level correlated
with poorer functional recovery.
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A platelet count (PLTC) that is elevated above a normal
value is defined as thrombocytosis. Thrombocytosis is
classified according to its origin: primary thrombocytosis
refers to haematological disorders; and secondary
thrombocytosis refers to several pathological clinical
conditions including infections [1], malignancy, chronic
inflammatory diseases [2-4] and critical illnesses [5,6].
Thrombocytosis is common among patients with severe
injuries admitted to intensive care units (ICU) [6] and
can be associated with significantly higher rates of ven-
ous thromboembolism [7]. The aetiology and clinical
significance of such elevated PLTC in patients with in-
juries remains unclear, even if it has been generally
recognised as a reactive phenomenon. Furthermore, al-
though severe anaemia requiring blood transfusion can
occur after major orthopaedic surgery, little is known
about the changes in the PLTC after these surgical inter-
ventions. Due to the risk of venous thromboembolism,
prophylactic treatment with subcutaneous low-weight
heparin is normally administered. However, physicians
worry about the heparin-induced thrombocytopoenia
that may occur during this treatment, since the condi-
tion may be life-threatening and require intervention [8].
Thrombocytosis is observed after surgery, particularly
after coronary artery by-pass [9] and major abdominal
operations. Abnormally elevated platelet level has also
been described after orthopaedic surgery [3,10,11] either
as one of several conditions involved in secondary
thrombocytosis [3] or as an unexpected finding after
prophylactic administration of enoxaparin [11]. Only
one study reported elevated PLTC after orthopaedic sur-
gery, but it focussed on extreme thrombocytosis [10]
and the authors were doubtful that the finding was
unique to that surgery. It is well known that blood pa-
rameters such as haemoglobin and albumin level can
hamper the functional outcome in subjects after major
joint surgery, particularly in older people [12,13]. On the
other hand, no investigation has been reported address-
ing PLTC changes after major joint surgery. Subjects
with elevated PLTC and thrombocytosis could be more
likely to develop venous thromboembolism after major
joint surgery and could have different outcomes. The
aim of the present study was to ascertain PLTC change
in patients who underwent major joint surgery and
whether those with elevated platelets were prone to
thrombotic events and to poor outcomes.
Methods
Consecutive patients discharged from the orthopaedic
unit and admitted to the intensive rehabilitation unit of
our hospital were identified. The ward uses multidiscip-
linary staff and a multidisciplinary approach to treating
patients. Our staff work in teams to apply managementand rehabilitation strategies coupled with a comprehensive
geriatric assessment aimed at preventing complications and
caring for concomitant diseases. With approval from the
ethics committee of our Hospital IRCCS “Casa Sollievo
della Sofferenza” and after obtaining written informed con-
sent, patients who had undergone hip and knee surgery
due to severe arthritis or fracture who required surgical
intervention or arthroplasty were enrolled. Those with
infections, malignancy, neurological diseases, renal and liver
failure, osteomyelitis, multiple trauma, rheumathoid arth-
ritis, primary thrombocytosis or previously ascertained
blood disorders were excluded because of potential con-
founding effects on the results.
Clinical and functional assessment
Comorbidities and data regarding the causes of major
joint surgery, including the type of orthopaedic surgery, the
time elapsed after surgery before rehabilitation admission,
and the length of stay were collected. Comorbidities were
evaluated using the Cumulative Illness Rating Scale (CIRS)
on admission [14]. A global functional evaluation was
undertaken using the Barthel Scale (BS) [15] and the Func-
tional Independence Measure (FIM) [16] on admission and
at discharge. A limitation of these scales lies in the defin-
ition of functional modifications in ambulation. To offset
this inadequacy, gait was independently classified into four
functional levels graded from zero to three: grade zero, no
gait or bedridden; grade one, uses a wheelchair; grade two,
uses a double support or walker; and grade three, walks un-
aided or uses a cane [17]. The BS provides a quantification
of the global functional recovery and dependence in some
of the basic activities of self-care. It ranges from zero to
100, with zero indicating a totally dependent, bedridden
state and 100 indicating that the patient is fully independ-
ent. The activities can be divided into behaviour that relates
to self-care (feeding, grooming, bathing, dressing, bowel
and bladder care and toilet use) and behaviour related to
mobility (ambulation, transfers and stairs climbing).
Motor and cognitive FIM subscales include 18 items.
Each item uses a seven-point ordinal scale from total
assistance (a score of one) to complete independence
(a score of seven). The motor FIM scores are divided
into four subscales that include 13 items as follows: self-
care (eating, grooming, bathing, upper body dressing, lower
body dressing, and toileting), sphincter control (bladder
management and bowel management), mobility (bed, chair
and wheelchair transfer, toilet transfer, and bathtub or
shower transfer), and locomotion (walking or wheelchair
and ability to climb stairs).
Assessment of platelet and blood parameters
Blood parameters including PLTC, red blood cells
(RBC), haemoglobin (Hb) and albumin level were
assessed on admission and at discharge. Furthermore,
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D-dimers were assessed at the same time. PLTC was
evaluated using an automatic counter (Coulter LH780,
Haematology Analyser, Beckman, Miami, USA). Blood
samples were collected in tubes with potassium EDTA
and were analysed 1 h after venipuncture. D-dimers
were measured using an Elisa technique (VidasD-dimer,
Biomerieux, France).
Degree of thrombocytosis
Thrombocytosis refers to a PLTC above the normal
value. For our laboratory, the normal PLTC range was
150–380 × 1009/L. A PLTC was considered elevated or
abnormal when the value was higher than the estab-
lished normal laboratory range. The PLTC for each
subject was recorded as either mildly high (381–500 ×
1009/L), high (501–600 × 1009/L), or very high (>600 ×
1009/L). Thrombocytosis was considered to be present
when a PLTC was greater than or equal to 500 × 1009/L.
All subjects with thrombocytosis underwent lower limb
duplex scan ultrasonography to assess deep venous
thrombosis (DVT) occurrence. The examination was
repeated in those who had persistent thrombocytosis at
discharge. Furthermore, in order to ascertain the differ-
ence in platelet change between old and young people,
the enrolled sample was divided into young and old
groups where the subjects ages were equal to or less
than 75 years or more than 75 years, respectively.
Rehabilitative interventions
All subjects received rehabilitation treatment for approxi-
mately two hours a day, six days per week in accordance
with their clinical condition. Upon admission, the subjects
were moved from beds to chairs. The rehabilitation pro-
gram consisted of joint mobilisation, proprioceptive neuro-
muscular facilitation, flexibility exercises, strength exercises
and gait training. An unrestricted weight-bearing regimen
was initiated in those who had TKA and THA. Subjects
with dynamic compression hip screws with a plate received
a gradually increasing load on the affected limb.
Statistical analysis
Longitudinal measures were analysed using repeated
measurements ANOVA. Between groups comparisons
were performed using the Mann–Whitney U test or un-
paired two-tailed Student’s t-test at each time point. The
Pearson chi-square test was used to compare categorical
variables. For the ANOVA analyses, values missing for a
patient were linearly interpolated. Correlations between
continuous variables were assessed using the Spearman
coefficient. A p-value < 0.05 was considered as statisti-
cally significant. All analyses were performed using SAS
Release 9.3 statistical software.Results
Two hundred and seventy-five subjects were identified.
Among these, 133 (63 male and 70 female, mean age
68.4 ± 9.3) subjects were excluded (19 due to neoplasm,
34 due to multiple trauma, 14 due to osteomyelitis, 18
due to severe renal and liver failure, 20 due to rheuma-
toid arthritis, 12 due to ascertained blood diseases and
16 subjects due to neurological disorders), and 142 sub-
jects were enrolled: 36 males and 106 females, mean age
77.2 ± 10.7 (range: 52–99) (Figure 1). Of the enrolled
sample, 60 (15 male and 45 female; mean age 66.9 ± 6.2,
range 52–75) and 82 (21 male and 61 female; mean age
84.7 ± 6.0, range 76–99) subjects were entered in the
young and old groups, respectively. Seventy-six (53.5%)
underwent total hip arthroplasty (THA), 40 (51.1%)
underwent hip internal fixation and 26 (18.3%) subjects
underwent total knee arthroplasty (TKA). Hip fracture
was prevalent in the old group (52 vs. 22, p = 0.0004).
Comorbidities were higher in old people than in young
people according to CIRS. The clinical characteristics
and type of orthopaedic surgery of the patients are reported
in Table 1. All patients who underwent TKA suffered from
severe knee osteoarthritis. The elapsed time from surgery
to admission in rehabilitation ward was 7 ± 2 days. Low
molecular weight heparin was administrated to all patients
in the month after the surgery to prevent thrombotic and/
or pulmonary embolic events. No difference in the number
of subjects or the number of peri-operative blood units
transfused was detected between the young and the old
group. Three elderly subjects who underwent THA devel-
oped pulmonary infections and were not included in the
analysis. Among these, one very old female subject died.
The mean length of stay was 35.4 ± 8.4 days. The length of
stay was longer in the old group than in the young group:
39.7 ± 7.1 and 29.1 ± 5.8, respectively (p < 0.0001).Platelet count
At admission, the mean PLTC was 394.8 ± 147 × 1009/L
(range 158–806 × 1009/L). Young people had significant
higher values of PLTC than old subjects: 437.8 ± 145.9
and 362.9 ± 140.5, respectively (p = 0.004). Fifty-nine
(42.4%) (42 female and 17 male) patients had PLTCs
above the normal value (mean value 503.8 ± 117.8 ×
1009/L, range 384–806 × 1009/L). Of these, 28 (20.1%;
21 female and seven male) had thrombocytosis with
PLTCs above 500 × 1009/L, and 15 (10.7%; 11 female
and four male) had a very high value above 600 × 1009/L.
None had PLTCs under the normal laboratory value.
Considering only those who had PLTC above 500 ×
1009, no statistically significant difference was found be-
tween young and old subjects (603.4 ± 102.6 vs. 640.4 ±
84.4, p = 0.34) or between females and males (619.4 ±
100.3 vs. 608.4 ± 91.1, p = 0.80).
Figure 1 Flow chart. Legend: THA = total hip arthroplasty; TKA = total knee arthroplasty.
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creased and the mean PLTC was within the normal la-
boratory value (300.4 ± 90.0 × 1009/L, range 104–599 ×
1009/L, p < 0.0001), except for two patients who had
low PLTC (104 and 122 × 1009/L). Platelets decreased
more, but not significantly in young than in old peopleTable 1 Clinical characteristics of surgical orthopaedic
subjects
Patients <= 75 y >75 y
Number 142 60 82
Age 77.2 (10.7) 66.9 (6.2) 84.7 (6.0)
Male 36 15 21
Female 106 45 61
CIRS 1.96 (1.07) 1.6 (1.2) 2.1 (0.9)
Type of surgery
THA 76 25 51
TKA 26 17 9
Internal fixation 40 12 38
Hip fracture 74 22 52
Hip arthritis 42 22 20
Knee arthritis 26 17 9
Time from surgery 7 (2)
Length of stay 35.7 (8.2) 29.5 (5.7) 39.7 (7.1)
Infections*/dead 3/1 - 3/1
Legend: CIRS = Cumulative Illness Rating Scale; THA = total hip arthroplasty;
TKA = total knee arthroplasty. Standard deviation is reported in brackets;
*pulmonary infections.(−110.8 ± 131.4 vs. -81.9 ± 106.9, p = 0.18) and more in
females than in males (−99.7 ± 118.3 vs. -76.9 ± 117.1,
p = 0.35). PLTC remained above 400 × 1009/L in 17
(12.2%) subjects (443.3 ± 51.7 × 1009/L) (Figure 2). Of
these, only three had high platelet values above 500 ×
1009/L. One subject with HTA developed severe
heparin-induced thrombocytopoenia requiring platelet
transfusion and was transferred to the haematological
ward. PLTC negatively correlated with the age at admis-
sion (r = −0.31, p = 0.0004) and at discharge (r = −0.25, p =
0.006). All patients with thrombocytosis underwent lower
limb duplex scan ultrasonography within one week of
PLTC detection (mean 5.1 ± 1, range 4–7 days). The
examination was repeated in all patients in whom the
PLTC was above 400 × 1009/L, at discharge. No subject
with thrombocytosis and persistently elevated PLTC had
lower limb DVT.
Blood parameters
At admission, the mean values of ESR, fibrinogen, and
D-dimers were elevated: 60.5 ± 25.4 (normal value: 2–
15 mm); 506.1 ± 116.8 mg/dl (normal value: 200–
450 mg/dl); and 580.7 ± 332.0 (normal value: 0–250 ng/ml);
respectively. Young subjects had non-significantly
higher values of ESR and fibrinogen than old people
(61.5 ± 24.4 vs. 59.7 ± 26.3, p = 0.71; 520.6 ± 110.3 vs.
496.4 ± 121.1 mg/dl, p = 0.36, respectively). Conversely,
old subjects had non-significantly higher mean value of
D-dimers than young people: 614 ± 345.6 vs. 542.8 ±
317.6 (p = 0.2). Females had non-significantly different
Figure 2 Platelet count in patients with major joint surgery.
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59.6 ± 17.2, p = 0.81; 491.8 ± 117.9 vs. 545.2 ± 106.5 mg/dl,
p = 0.07, respectively). At discharge, ESR, fibrinogen
and D-dimers mean values were significantly decreased:
38.1 ± 25.4, 393.3 ± 223.9 mg/dl, and 299.3 ± 168.2 ng/
ml (p < 0.0001), respectively (Table 2). ESR decreased
more, but not significantly so in young compared with
old people (−37.1 ± 25.3 vs. -27.7 ± 26.7, p = 0.33) and
in females compared with males (−34.0 ± 27.5 vs. -30.2 ±
16.5, p = 0.77). Fibrinogen decreased more, but not signifi-
cantly so in young compared with old subjects (−215.8 ±
206.3 vs. -135.5 ± 103.9, p = 0.64) and in males compared
with females (−320.0 ± 311.1 vs. -142.0 ± 109.7, p = 0.27).
At admission, all subjects had mild anaemia as charac-
terised by reduced RBC count and low Hb level (10.3 ±
2.4 gr/dl) that was significantly improved at discharge
(11.2 ± 2 gr/dl. p < 0.0001). One female patient received
a blood transfusion during her in-hospital rehabilitationTable 2 Mean PLTC, blood parameters and functional outcom
admission to and discharge from the rehabilitation unit
Admission
Patients <75 y >75 y
PLTC 394.8* (147.0) 437.8*§ (145.9) 362.9* (140.5
ESR 60.5 (25.4)* 61.5 (24.4)* 59.7 (26.3)*
Fibrinogen 506.1* (116.8) 520.6* (110.2) 496.4* (121.1







Hb 10.3 (2.4)* 10.4 (2.9)* 10.2 (2)*
Functional
measures
Gait 1.3 (0.8) 1.8 (0.3)^ 0.9 (0.8)
BS 47.2 (22.5) 60.3 (15.3)§ 36.0 (21.7)
FIM 66.5 (25.3) 82.5 (13.1)§ 54.8 (25.6)
Legend: PLTC = platelet count × 1009/L; ESR = erythrocyte sedimentation rate; Hb =
independence measure; standard deviation is reported in brackets; *p < 0.0001 (adm
(discharge vs. admission); ^p < 0.0001 (young vs. old people); & p < 0.0001 (young v
compared to old people).stay, but she was not included in the analysis due to
pulmonary infection.
Functional outcome
On admission, the mean scores of the assessed func-
tional measures were: 66.5 ± 25.3 and 47.2 ± 22.5 for
FIM and BS, respectively. Old subjects had significantly
poorer functionality than young ones according to FIM:
54.2 ± 25.6 vs. 82.5 ± 13.1 (p < 0.0001), and according to
BS: 36.0 ± 21.7 vs. 60.3 ± 15.3 (p < 0.0001).
After rehabilitation treatment, functional improvement
was observed: 97.8 ± 29.4 and 82.7 ± 23.4 (p < 0.0001) for
FIM and BS, respectively. However, the young had sig-
nificantly better outcomes than elder people in all func-
tional assessment measures: 116.4 ± 10.9 vs. 83.6 ± 31.2,
and 97.0 ± 6.9 vs. 70.5 ± 25.6 (p = 0.004) in the young
and old groups for FIM and BS, respectively, at dis-
charge (Table 2). Likewise, significant improvement ine in patients with major orthopaedic surgery at
Discharge
Patients <75 y >75 y
) 300.4 (90.0) 328.2$ (89.1) 281.0 (86)
38.1 (25.4) 32.9 (26.5) 45.1 (23)
) 393.3 (223.9) 394.4 (264.4) 390.5 (145.0)







11.2 (2) 11.3 (0.8) 11.2 (2.6)
2.5 (0.7)** 2.9 (0.2)& 2.2 (0.8)**
82.7 (23.4)** 97 (6.9)§** 70.5 (25.6)**
97.8 (29.4)** 116.4 (10.9)§** 83.6 (31.2)**
haemoglobin; RBC = red blood cells; BS = Barthel Scale; FIM = functional
ission vs. discharge); £p = 0.025 (discharge vs. admission); **p = 0.0001
s. old people); §p = 0.004 (young compared to old); $p = 0.002 (young
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(2.5 ± 0.7 vs. 1.3 ± 0.8; p < 0.0001), but young people had
better outcomes than old people: 2.9 ± 0.2 and 2.2 ± 0.8
(p < 0.0001), respectively (Table 2). Significant positive
correlation between FIM and RBC was observed (p = 0.04)
at discharge. Furthermore, BS and FIM positively correlated
with Hb and albumin level (3.2 ± 0.3 and 3.6 ± 0.3 gr/dl,
both on admission and discharge). Age was negatively cor-
related with platelet count at admission (r = −0.31, p =
0.0004) and at discharge (r = −0.25, p = 0.006). Age was
negatively correlated with FIM and BS both at admis-
sion (r = −0.67, p < 0.0001; r = −0.63, p < 0.0001) and at
discharge (r = −0.70, p < 0.0001; r = −0.66, p < 0.0001).
Discussion
Change in platelet counts was a common phenomenon
after major joint surgery, and elevated PLTC occurred in
about half of the patients who were admitted to the re-
habilitation centre. Thrombocytosis was not an uncom-
mon event, since 20.1% of the sample had a PLTC above
500 × 1009/L, but this condition did not affect the func-
tional outcome. Despite the risk of thromboembolism
being a great concern in patients with thrombocytosis,
no subject with elevated PLTC developed lower limb DVT.
Some of the most common causes of secondary
thrombocytosis include soft-tissue, pulmonary and gastro-
intestinal infections, as well as tissue damage and malig-
nancy [1]. Furthermore, thrombocytosis is a common
finding among patients with trauma, injuries and surgical
interventions admitted to the ICU [6]. The significance of
elevated PLTC in critically ill patients has not been clearly
elucidated, although this sequela has generally been con-
sidered a benign finding. Only one study has been pub-
lished reporting elevated PLTC or thrombocytosis after
major orthopaedic surgery [10]. Surprisingly 163 (79.1%)
of 206 subjects had elevated PLTC, with values from 400
to 450 × 1009/L. However, the authors focussed on ex-
treme thrombocytosis, ascribing this finding to alcohol
abuse and infections, and they were doubtful whether
the finding was unique to orthopaedic surgery. Among
secondary thrombocytosis, surgery including coronary
artery by-pass, major abdominal surgery and especially
splenectomy [3,1] are fairly common. Orthopaedic surgery
was also reported as being associated with secondary
thrombocytosis, but the finding concerned retrospective
studies and thrombocytosis was generally attributed to
other causes such as trauma and tissue damage [1]. To our
knowledge, this is the first prospective study with a
homogenous orthopaedic surgical sample and it demon-
strates that high PLTCs occur in 42.4% of patients after
major joint surgery. The role and significance elevated
platelets might play in this clinical condition is unclear,
though several hypotheses can be suggested. The major
functions of platelets are to prevent acute blood loss and torepair vascular walls and adjacent tissues after a local injury.
To accomplish this, platelets secrete many mediators and
cytokines that stimulate tissue regeneration by cell prolifer-
ation, cell migration and angiogenesis [18]. It has been re-
ported that more than 800 different proteins are released
that act on different cell types, including osteoblasts [19],
fibroblasts, chondrocytes, myocytes, and tendon cells
[20-22]. Therefore, it could be postulated that major
orthopaedic interventions activate physiological pro-
cesses that heal the surgical wound, similar to the pro-
cesses occurring during local injury. An increase in the
amount of platelets may represent a component of that
complex network of cells and inflammatory mediators
that are activated following injury in order to repair
and regenerate the damaged tissue. The observed in-
crease in ESR, fibrinogen and D-dimer levels could also
be considered as a further expression of an inflamma-
tory response to repair the surgical wound. In the
present study, elevated PLTC and inflammatory prod-
ucts were detected at about 7–12 days after surgery,
when the patients were admitted to the rehabilitation
unit. A similar finding was reported by Ziaja et al., who
detected thrombocytosis two weeks after surgical interven-
tion [11]. Likewise, in a study by Bunting et al., the highest
PLTC occurred from nine to 22 days (mean 14 ± 3.0) after
surgery [10]. Since platelets secrete many mediators and cy-
tokines for at least seven days after a local injury [18], this
time period could represent the peak of an adaptive
response. In order to evaluate a potential age effect on
platelet change, the enrolled subjects were divided in two
groups according to an age cut-off of 75 years. Young
people had significantly higher platelet counts than old
people, at all time points. This finding could be explained
by a better or more evident reactive-reparative response to
the injury in young people compared with old people. It is
also possible to consider that platelet change in old people
is simply due to the progressive physiological multi-organ
decline which occurs during ageing. A recent survey of
PLTC in a large national cohort population found that the
number of platelets decreases quickly in childhood, stabi-
lises in adulthood, and further decreases with age [23]. The
risk of thromboembolic events remains the greatest con-
cern in patients with thrombocytosis, and subjects with ele-
vated PLTC could be more likely to develop venous
thromboembolism occurrence after major joint surgery.
However, the relationship between elevated PLTC and these
adverse events has not been established. One study by
Salim et al. reported that there was a trend toward in-
creased DVT, and a significantly higher rate of pulmonary
embolism among patients developing thrombocytosis after
severe trauma. However, this was not found in similar stud-
ies [3,6]. Despite this concern, no subject with thrombocy-
tosis developed DVT in the present study. Global
functional improvement was detected after rehabilitation
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outcome. Similarly, a previous study reported that mortality
risk was not correlated with PLTC in hip fracture patients
[24]. On the other hand, univariate analysis of variables in-
cluding age and blood parameters showed that these factors
have an important role in functional recovery. Age was
negatively correlated with FIM and BS both at admission
and at discharge. Furthermore, BS and FIM were positively
correlated with haemoglobin and albumin level. Similar
findings have been reported in previous studies addressing
the relationship between blood parameters, functional out-
comes and mortality risk [12,25,26] in subjects undergoing
joint surgery. The findings indicate that patients admitted
to rehabilitation after major joint surgery have the potential
for improvement in motor function and global functional-
ity, but those with lower haemoglobin and albumin level
and those who are older may expect longer hospital stays
and poorer functional outcomes. Indeed, older people
stayed in hospital longer and had significantly poorer out-
comes than young people according to all of the functional
assessment measures employed. Furthermore, significantly
better gait recovery was observed in young compared with
old people.Conclusion
Changes in platelet levels occurred after major joint surgery
in patients admitted to a rehabilitation unit and elevated
PLTC with thrombocytosis was not uncommon. This
phenomenon may be a component of the underlying in-
flammatory process that acts to repair and heal the dam-
aged tissue, but it does not promote DVT occurrence.
Functional outcome was not affected by platelet changes or
thrombocytosis. On the other hand, advanced age and low
haemoglobin level predicted poor outcome.
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